个人中心 - 老虎社区

Amins

IP属地：未知

帖子 · 92帖子 · 92
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- AminsAmins
  ·2021-09-30
  Ya
  非常抱歉，此主贴已删除
  1,110 1
  1
  分享
  举报
- AminsAmins
  ·2021-09-19
  Noooo
  非常抱歉，此主贴已删除
  416 1
  3
  分享
  举报
- AminsAmins
  ·2021-09-07
  Yup
  非常抱歉，此主贴已删除
  727 1
  3
  分享
  举报
- AminsAmins
  ·2021-09-02
  No god no please no!!
  非常抱歉，此主贴已删除
  483 3
  3
  分享
  举报
- AminsAmins
  ·2021-08-11
  Hmmmmm
  非常抱歉，此主贴已删除
  729 2
  4
  分享
  举报
- AminsAmins
  ·2021-07-29
  Niceeee
  非常抱歉，此主贴已删除
  630 1
  4
  分享
  举报
- AminsAmins
  ·2021-07-28
  Lets beat cancer!!
  TYME Stock: The Cancer Treatment News That’s Boosting Tyme Today
  While the focus for most of last week and today has been centered around cryptocurrency and public o
  TYME Stock: The Cancer Treatment News That’s Boosting Tyme Today
  699 1
  1
  分享
  举报
- AminsAmins
  ·2021-07-26
  Netflix and chill!
  非常抱歉，此主贴已删除
  496 评论
  6
  分享
  举报
- AminsAmins
  ·2021-07-20
  Niceeee
  非常抱歉，此主贴已删除
  488 4
  3
  分享
  举报
- AminsAmins
  ·2021-07-18
  Hmmmmm
  非常抱歉，此主贴已删除
  466 6
  3
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3580565594783380","uuid":"3580565594783380","gmtCreate":1617471571074,"gmtModify":1619154652740,"name":"Amins","pinyin":"amins","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":14,"tweetSize":92,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.57%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":865649791,"gmtCreate":1632980354865,"gmtModify":1632980452859,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Ya","listText":"Ya","text":"Ya","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865649791","repostId":"2165880909","repostType":4,"isVote":1,"tweetType":1,"viewCount":1110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887678140,"gmtCreate":1632035723580,"gmtModify":1632803189282,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Noooo","listText":"Noooo","text":"Noooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/887678140","repostId":"1146170136","repostType":4,"isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":817717829,"gmtCreate":1630988261261,"gmtModify":1631890704069,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Yup","listText":"Yup","text":"Yup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/817717829","repostId":"2165880909","repostType":4,"isVote":1,"tweetType":1,"viewCount":727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812697632,"gmtCreate":1630580445526,"gmtModify":1631890704070,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"No god no please no!!","listText":"No god no please no!!","text":"No god no please no!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/812697632","repostId":"1146170136","repostType":4,"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895061458,"gmtCreate":1628695095774,"gmtModify":1631890704069,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Hmmmmm","listText":"Hmmmmm","text":"Hmmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/895061458","repostId":"1149859103","repostType":4,"isVote":1,"tweetType":1,"viewCount":729,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801501405,"gmtCreate":1627521265307,"gmtModify":1631890704086,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Niceeee","listText":"Niceeee","text":"Niceeee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801501405","repostId":"1166151449","repostType":4,"isVote":1,"tweetType":1,"viewCount":630,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803108237,"gmtCreate":1627426634429,"gmtModify":1631890704087,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Lets beat cancer!!","listText":"Lets beat cancer!!","text":"Lets beat cancer!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/803108237","repostId":"1123658607","repostType":2,"repost":{"id":"1123658607","kind":"news","pubTimestamp":1627347222,"share":"https://www.laohu8.com/m/news/1123658607?lang=&edition=full","pubTime":"2021-07-27 08:53","market":"us","language":"en","title":"TYME Stock: The Cancer Treatment News That’s Boosting Tyme Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1123658607","media":"investorplace","summary":"While the focus for most of last week and today has been centered around cryptocurrency and public o","content":"<p>While the focus for most of last week and today has been centered around cryptocurrency and public offerings, biotech companies have been quietly making a killing. New deals, patents, expansions and clinical trial results have been pushing a great deal of medical stocks upward at impressive rates. Joining the ranks of big gainers today is&nbsp;<b>Tyme Technologies</b>(NASDAQ:<b><u>TYME</u></b>). Thanks to the announcement of a patent approval, TYME stock is soaring quite high.</p>\n<p>Tyme is a Bedminster, New Jersey-based, small cap biotech outfit. The company develops cancer metabolism-based therapies, or CMBTs, which take advantage of cancer cells’ differing metabolic functions to kill them. The company is announcing today some great news in the form of apatent approval. The patent will protect Tyme’s development of its CMBT treatment product.</p>\n<p>The company’s CMBT therapy is an oral therapy that combines tyrosine with a therapeutic agent. In essence, tyrosine is one of the non-essential amino acids on which cancer cells feverishly consume. Cancer cells need far more of these compounds because they don’t produce enough of their own. Since cancer cells metabolize far greater amounts of these non-essential components than the average cell, the therapeutic agent is more easily introduced to these cells. The agent then kills the cell.</p>\n<p>TYME Stock Soars on Patent News</p>\n<p>According to Tyme’s CSO, Steve Hoffman, the company plans to move forward with the development of the therapy in a way that is even safer and more effective than its current formula. All in all, this news is great for investors; with a patent secured, and an already promising initial product in the books, there are further growth prospects for TYME stock, which will attract new investors.</p>\n<p>The news is already paying off nicely for TYME. The stock is up over 72% on the news, and volume is massively increasing. 214 million shares of TYME are changing hands today, far greater than the average 2.7 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TYME Stock: The Cancer Treatment News That’s Boosting Tyme Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTYME Stock: The Cancer Treatment News That’s Boosting Tyme Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/tyme-stock-the-cancer-treatment-news-thats-boosting-tyme-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While the focus for most of last week and today has been centered around cryptocurrency and public offerings, biotech companies have been quietly making a killing. New deals, patents, expansions and ...</p>\n\n<a href=\"https://investorplace.com/2021/07/tyme-stock-the-cancer-treatment-news-thats-boosting-tyme-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TYME":"Tyme Technologies, Inc."},"source_url":"https://investorplace.com/2021/07/tyme-stock-the-cancer-treatment-news-thats-boosting-tyme-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123658607","content_text":"While the focus for most of last week and today has been centered around cryptocurrency and public offerings, biotech companies have been quietly making a killing. New deals, patents, expansions and clinical trial results have been pushing a great deal of medical stocks upward at impressive rates. Joining the ranks of big gainers today is Tyme Technologies(NASDAQ:TYME). Thanks to the announcement of a patent approval, TYME stock is soaring quite high.\nTyme is a Bedminster, New Jersey-based, small cap biotech outfit. The company develops cancer metabolism-based therapies, or CMBTs, which take advantage of cancer cells’ differing metabolic functions to kill them. The company is announcing today some great news in the form of apatent approval. The patent will protect Tyme’s development of its CMBT treatment product.\nThe company’s CMBT therapy is an oral therapy that combines tyrosine with a therapeutic agent. In essence, tyrosine is one of the non-essential amino acids on which cancer cells feverishly consume. Cancer cells need far more of these compounds because they don’t produce enough of their own. Since cancer cells metabolize far greater amounts of these non-essential components than the average cell, the therapeutic agent is more easily introduced to these cells. The agent then kills the cell.\nTYME Stock Soars on Patent News\nAccording to Tyme’s CSO, Steve Hoffman, the company plans to move forward with the development of the therapy in a way that is even safer and more effective than its current formula. All in all, this news is great for investors; with a patent secured, and an already promising initial product in the books, there are further growth prospects for TYME stock, which will attract new investors.\nThe news is already paying off nicely for TYME. The stock is up over 72% on the news, and volume is massively increasing. 214 million shares of TYME are changing hands today, far greater than the average 2.7 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177548684,"gmtCreate":1627255242048,"gmtModify":1631885615281,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Netflix and chill!","listText":"Netflix and chill!","text":"Netflix and chill!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/177548684","repostId":"1115106146","repostType":4,"isVote":1,"tweetType":1,"viewCount":496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171614586,"gmtCreate":1626741824445,"gmtModify":1631890704095,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Niceeee","listText":"Niceeee","text":"Niceeee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/171614586","repostId":"2152651282","repostType":4,"isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179703315,"gmtCreate":1626574744237,"gmtModify":1631893813439,"author":{"id":"3580565594783380","authorId":"3580565594783380","name":"Amins","avatar":"https://static.tigerbbs.com/e27267c412cea01bdd4a47d746ba7606","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580565594783380","authorIdStr":"3580565594783380"},"themes":[],"htmlText":"Hmmmmm","listText":"Hmmmmm","text":"Hmmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/179703315","repostId":"1123523681","repostType":4,"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":false}